Form 4 for BSX Boston Scientific
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001225208-25-001793 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-14 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,115 | 30.6K | +7% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $105.77 | -868 | 29.7K | -3% | -$91.8K |
| D | 2025-02-14 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | -2,115 | 6,347 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | M | A | 2,115 | $0.00 | 30,569 | D | — | — | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| 2 | Common | Common Stock | 2025-02-12 | F | D | 868 | $105.77 | 29,701 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-02-12 | M | D | 2,115 | $0.00 | 6,347 | D | — · — to 2028-02-12 | 2,115 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. |